Helping people in subsidized housing create smoke-free homes
Official title: A smoke-free home intervention in federally subsidized housing
Funded at University of California, San Francisco · NIH-11036321 · Data updated 2026-11-12
This study is all about helping people from different backgrounds who live in subsidized housing to quit smoking and create smoke-free homes, especially focusing on those who might need extra support, like Black, Hispanic, and Asian individuals who speak limited English.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | August 15, 2023 |
| Project end | February 29, 2028 |
| Funding year | 2025 |
| Award (this year) | $681,194 |
| NIH project number | 5R01MD016898-03 |
| Project ID | NIH-11036321 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living in federally subsidized housing, particularly from racially and ethnically diverse backgrounds.
✕Less likely to help
Patients who do not reside in federally subsidized housing or who do not use tobacco may not benefit from this research.
What this research studies
This research focuses on reducing tobacco use and exposure among racially and ethnically diverse populations living in federally subsidized housing. It aims to increase access to smoke-free homes and cessation resources, particularly for Black/African American, Hispanic/Latino, and Asian individuals with limited English proficiency. The study will implement and promote smoke-free policies and voluntary adoption of smoke-free homes, building on previous pilot work to assess effectiveness and feasibility. Participants will receive support and resources to help them transition to smoke-free living environments.
Why it matters
Potential benefit: If successful, this research could lead to healthier living conditions and reduced tobacco-related health disparities for residents in subsidized housing.
How similar studies have gone: Previous research has shown that smoke-free policies can effectively reduce tobacco use and exposure, indicating a promising approach for this intervention.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Vijayaraghavan, Maya — University of California, San Francisco
- Study coordinator: Vijayaraghavan, Maya
Related research
Other NIH-funded projects on the same topics.
-
How cancer cells use exosomes to evade the immune system
This study is looking at how cancer cells use tiny bubbles called exosomes to hide proteins that can keep your immune system from fighting the tumor, and by figuring this out, the researchers hope to help doctors understand why some people respond well to cancer treatments while others don’t, ultimately aiming to creat
-
Reducing harm from smoking using electronic cigarettes
This study is looking at whether using electronic cigarettes can be a safer option for people who smoke traditional cigarettes, by comparing the health effects and exposure to harmful substances between the two.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Cutaneous opioid signals in skin inflammation
A mentor-identified clinician-researcher at UCSF is studying how natural skin opioids regulate itch and pain in inflammatory skin conditions like eczema and hidradenitis, with plans to map where these opioids come from and how they affect skin nerves.
-
Pooling international data to understand long-term bisphosphonate use and atypical femur fractures
This project combines large patient datasets from multiple countries to understand how long-term bisphosphonate use relates to rare hip and thigh bone fractures, helping doctors and patients make safer treatment choices.
-
Airway cell and immune cell talks in lung transplant failure
This grant tests how airway cells and immune cells interact to drive chronic rejection after lung transplant, with the goal of slowing or preventing scar-like damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.